M Hemshekhar, RM Thushara… - International Journal of …, 2016 - Elsevier
Hyaluronic acid (HA), is a glycosaminoglycan comprised of repeating disaccharide units of N-acetyl-d-glucosamine and d-glucuronic acid. HA is synthesized by hyaluronan synthases …
E Karousou, S Misra, S Ghatak, K Dobra, M Götte… - Matrix Biology, 2017 - Elsevier
Synthesis, deposition, and interactions of hyaluronan (HA) with its cellular receptor CD44 are crucial events that regulate the onset and progression of tumors. The intracellular …
AK Mitra, V Agrahari, A Mandal, K Cholkar… - Journal of controlled …, 2015 - Elsevier
Currently, a majority of cancer treatment strategies are based on the removal of tumor mass mainly by surgery. Chemical and physical treatments such as chemo-and radiotherapies …
Now-a-days, the polysaccharides are extensively employed for the delivery of small- molecule drugs ascribed to their excellent biocompatibility, biodegradability and …
S Bastaki, S Aravindhan, NA Saheb, MA Kashani… - Life Sciences, 2021 - Elsevier
Immunotherapy methods using potential tumor microenvironment modulators have elicited durable therapeutic responses in cancer treatment. Immune checkpoint molecule …
Based on the overexpression of specific receptors on tumor cells, active targeting nanomedicines have been developed with the ability to efficiently deliver imaging agents in …
S Adityan, M Tran, C Bhavsar, SY Wu - Journal of controlled release, 2020 - Elsevier
Nanoparticles (NPs) that permit active targeting promise to play a key role in cancer therapy moving forward. However, in order to successfully advance into clinic, these delivery …
JS Crabtree, L Miele - Biomedicines, 2018 - mdpi.com
Breast cancer stem cells (BCSC) have been implicated in tumor initiation, progression, metastasis, recurrence, and resistance to therapy. The origins of BCSCs remain …
Polymer therapeutics encompasses polymer–drug conjugates that are nano-sized, multicomponent constructs already in the clinic as antitumor compounds, either as single …